Sweetness in the Blood: Race, Risk, and Type 2 Diabetes by James Doucet-Battle (

Description: FREE SHIPPING UK WIDE Sweetness in the Blood by James Doucet-Battle "James Doucet-Battle offers an important critical examination of the assumptions behind the recruitment of African American and African-descent populations for Type 2 diabetes research"-- FORMAT Paperback LANGUAGE English CONDITION Brand New Publisher Description A bold new indictment of the racialization of science Decades of data cannot be ignored: African American adults are far more likely to develop Type 2 diabetes than white adults. But has science gone so far in racializing diabetes as to undermine the search for solutions? In a rousing indictment of the idea that notions of biological race should drive scientific inquiry, Sweetness in the Blood provides an ethnographic picture of biotechnologys framings of Type 2 diabetes risk and race and, importantly, offers a critical examination of the assumptions behind the recruitment of African American and African-descent populations for Type 2 diabetes research.James Doucet-Battle begins with a historical overview of how diabetes has been researched and framed racially over the past century, chronicling one companys efforts to recruit African Americans to test their new diabetes risk-score algorithm with the aim of increasing the clinical and market value of the firms technology. He considers African American reticence about participation in biomedical research and examines race and health disparities in light of advances in genomic sequencing technology. Doucet-Battle concludes by emphasizing that genomic research into sub-Saharan ancestry in fact underlines the importance of analyzing gender before attempting to understand the notion of race. No disease reveals this more than Type 2 diabetes.Sweetness in the Blood challenges the notion that the best approach to understanding, managing, and curing Type 2 diabetes is through the lens of race. It also transforms how we think about sugar, filling a neglected gap between the sugar- and molasses-sweetened past of the enslaved African laborer and the high-fructose corn syrup- and corporate-fed body of the contemporary consumer-laborer. Author Biography James Doucet-Battle is assistant professor of sociology at the University of California, Santa Cruz. Table of Contents ContentsAbbreviationsIntroduction. Sugars Racial Project: From Slavery to Diabetes1. The At-Risk Ethnographer of Sweetness2. Sweet Blood: Inventing the Prediabetic3. Algorithms of Risk and Race: Recruiting Black Risk and Marketing Black Bodies4. A Dark Past in Present Light: The Black Church, Medicine, and Trust5. The Ascension of the Black Matriarch: The Search for Metabolic AfricaConclusion. The Racialized Pancreas: Toward Biosocial JusticeAcknowledgmentsA Subversive GlossaryNotesIndex Review "James Doucet-Battle has given us a brilliant book that uncovers the networks that support the pharmacapitalism of Type 2 diabetes. In this important study, we see the impact of economizing risk through biomarketing. Sweetness in the Blood is a must-read because it underscores the sacrificial labor of Black people as they become the targets of risk assessments for Type 2 diabetes and role that the technology plays in constructing racial risk."—Dána-Ain Davis, author of Reproductive Injustice: Racism, Pregnancy, and Premature Birth"Sweetness in the Blood is an indictment, not only of the global sugar industry, but of medical and biotech industries that insist on using biological race as a lens to explain and predict health disparities. Traversing breathtaking terrain, from sugar plantations to pharmaceutical board rooms, this is a must-read for everyone who wants to understand how social inequity gets under the skin and for all those committed to health justice."—Ruha Benjamin, author of Race After Technology"Sweetness in the Blood adds nuance to our understanding of race and chronic disease prevention management."—Ethnic and Racial Studies"In Sweetness in the Blood: Race, Risk, and Type 2 Diabetes, James Doucet-Battle offers a sweeping indictment of ways in which racial essentialism infiltrates the science and industry surrounding modern diabetes."—Social Forces"In this important contribution to deconstructing the intersections of race, capital, and disease, Doucet-Battle employs an ethnographic approach to explore the racialization of a disease, showing how the combined enterprises of pharma and medicine have constructed being African American as a risk. "—CHOICE"Doucet-Battle successfully presses his readers to question a handful of taken-for-granted concepts (i.e., race, risk, and diabetes). In that respect, Sweetness in the Blood is a wonderful example of the sociological craft. "—American Journal of Sociology Long Description A bold new indictment of the racialization of science Decades of data cannot be ignored: African American adults are far more likely to develop Type 2 diabetes than white adults. But has science gone so far in racializing diabetes as to undermine the search for solutions? In a rousing indictment of the idea that notions of biological race should drive scientific inquiry, Sweetness in the Blood provides an ethnographic picture of biotechnologys framings of Type 2 diabetes risk and race and, importantly, offers a critical examination of the assumptions behind the recruitment of African American and African-descent populations for Type 2 diabetes research. James Doucet-Battle begins with a historical overview of how diabetes has been researched and framed racially over the past century, chronicling one companys efforts to recruit African Americans to test their new diabetes risk-score algorithm with the aim of increasing the clinical and market value of the firms technology. He considers African American reticence about participation in biomedical research and examines race and health disparities in light of advances in genomic sequencing technology. Doucet-Battle concludes by emphasizing that genomic research into sub-Saharan ancestry in fact underlines the importance of analyzing gender before attempting to understand the notion of race. No disease reveals this more than Type 2 diabetes. Sweetness in the Blood challenges the notion that the best approach to understanding, managing, and curing Type 2 diabetes is through the lens of race. It also transforms how we think about sugar, filling a neglected gap between the sugar- and molasses-sweetened past of the enslaved African laborer and the high-fructose corn syrup- and corporate-fed body of the contemporary consumer-laborer. Review Quote "James Doucet-Battle has given us a brilliant book that uncovers the networks that support the pharmacapitalism of Type 2 diabetes. In this important study, we see the impact of economizing risk through biomarketing. Sweetness in the Blood is a must-read because it underscores the sacrificial labor of Black people as they become the targets of risk assessments for Type 2 diabetes and role that the technology plays in constructing racial risk."--D Details ISBN1517908493 Short Title Sweetness in the Blood Pages 240 Language English Year 2021 ISBN-10 1517908493 ISBN-13 9781517908492 Format Paperback Subtitle Race, Risk, and Type 2 Diabetes Imprint University of Minnesota Press Place of Publication Minnesota Country of Publication United States NZ Release Date 2021-03-16 US Release Date 2021-03-16 Publication Date 2021-03-16 UK Release Date 2021-03-16 Author James Doucet-Battle Publisher University of Minnesota Press Alternative 9781517908485 DEWEY 616.4624 Audience General AU Release Date 2021-05-24 We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! 30 DAY RETURN POLICY No questions asked, 30 day returns! FREE DELIVERY No matter where you are in the UK, delivery is free. SECURE PAYMENT Peace of mind by paying through PayPal and eBay Buyer Protection TheNile_Item_ID:161854088;

Price: 32 GBP

Location: London

End Time: 2024-12-21T03:00:55.000Z

Shipping Cost: 2.69 GBP